A Study to Test Safety and Efficacy of Baricitinib in Participants With Diabetic Kidney Disease
Clinical trial NCT01683409 · COMPLETED
Trial details
- NCT number
- NCT01683409
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-08-01
- Primary completion
- 2014-09-01
- Enrollment
- 130
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.